Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Publication year range
1.
Acta otorrinolaringol. esp ; 67(3): 162-166, mayo-jun. 2016. tab, ilus
Article in Spanish | IBECS | ID: ibc-151779

ABSTRACT

La pandemia tuberculosa supone un problema de salud pública para muchos países, ya sean ricos o pobres. Su localización ORL extraganglionar es poco frecuente, y en la región faríngea predomina en el cavum. En un estudio retrospectivo sobre 3 años, se intentan poner de relieve, a través de 5 casos clínicos de tuberculosis faríngea, los aspectos epidemiológicos, clínicos, radiológicos, terapéuticos y pronósticos de esta enfermedad. Sus aspectos clínicos no son específicos, y suelen prestarse a confusión con afección tumoral. El diagnóstico positivo se orienta por los datos clínicos y radiológicos y se confirma por anatomopatología (AU)


Tuberculosis is a public health problem for many countries, whether rich or poor. Extranodal ENT locations are rare, and it prevails in the cavum in the pharyngeal region. Based on a 3-year retrospective study of 5 clinical cases, the authors aim to highlight the epidemiological, clinical, radiological, therapeutic and prognostic aspects of this disease. Clinical aspects are not specific and there is often confusion in the differential diagnosis with tumoral lesions. Positive diagnosis is guided by the clinical and the radiological findings, and confirmed by histology (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Tuberculosis/epidemiology , Tuberculosis , Pharynx , Diagnosis, Differential , Mycobacterium tuberculosis/pathogenicity , Tuberculosis, Multidrug-Resistant , Drug Resistance, Multiple/physiology , Pharyngeal Diseases/complications , Pharyngeal Diseases/diagnosis , Pharyngeal Diseases , Otolaryngology/methods , Retrospective Studies , Endemic Diseases/prevention & control
2.
Acta Otorrinolaringol Esp ; 67(3): 162-6, 2016.
Article in English, Spanish | MEDLINE | ID: mdl-26277737

ABSTRACT

Tuberculosis is a public health problem for many countries, whether rich or poor. Extranodal ENT locations are rare, and it prevails in the cavum in the pharyngeal region. Based on a 3-year retrospective study of 5 clinical cases, the authors aim to highlight the epidemiological, clinical, radiological, therapeutic and prognostic aspects of this disease. Clinical aspects are not specific and there is often confusion in the differential diagnosis with tumoral lesions. Positive diagnosis is guided by the clinical and the radiological findings, and confirmed by histology.


Subject(s)
Pharyngitis/epidemiology , Tuberculosis/epidemiology , Antitubercular Agents/therapeutic use , Drug Therapy, Combination , Follow-Up Studies , Humans , Mycobacterium tuberculosis/isolation & purification , Pandemics , Pharyngitis/diagnosis , Pharyngitis/diagnostic imaging , Pharyngitis/drug therapy , Retrospective Studies , Tomography, X-Ray Computed , Tuberculin Test , Tuberculosis/diagnosis , Tuberculosis/diagnostic imaging , Tuberculosis/drug therapy
3.
BMC Res Notes ; 8: 665, 2015 Nov 11.
Article in English | MEDLINE | ID: mdl-26559779

ABSTRACT

BACKGROUND: Splenic abcess is an uncommon complication for cancer treatment. It occurs more frequently in immunocompromised patients. They are characterized by high mortality. The classic triad (fever, pain of the left hypochondrium, and sensitive mass left) is only present in one-third of cases the clinical spectrum ranging from no symptoms to events such as fever, nausea, vomiting, weight loss, abdominal pain left, splenomegaly. Treatment options are limited, but must be discussed and adapted to the patient profile. CASE PRESENTATION: We report the case of a 62-year-old Arabic male, diagnosed with metastatic lung adenocarcinoma, who, after several cycles of chemotherapy, presented symptoms and signs of splenic abcess. CONCLUSION: Splenic abcess is rare situation, which must be actively researched, to have access to an optimal therapeutic approach.


Subject(s)
Abscess/diagnosis , Adenocarcinoma/drug therapy , Antimitotic Agents/therapeutic use , Lung Neoplasms/drug therapy , Splenic Diseases/diagnosis , Abscess/drug therapy , Abscess/surgery , Adenocarcinoma/pathology , Anti-Bacterial Agents/therapeutic use , Combined Modality Therapy , Humans , Lung Neoplasms/pathology , Male , Middle Aged , Neoplasm Metastasis , Splenectomy , Splenic Diseases/drug therapy , Splenic Diseases/surgery , Splenomegaly , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL